
Features traceable origins, clear IP ownership and global commercial licensing, eliminating IP risks for worldwide drug development, registration and commercialization.
Our portfolio spans overexpression, reporter, and cell lines covering hot targets and core applications for mAb, bsAb and cell therapy development.
Undergoing in-depth optimization and systematic functional validation to satisfy your research needs ranging from assay development to pharmacodynamic evaluation.



MOA-based luciferase reporter cells correlate target signaling to monitor intracellular transduction pathways for drug R&D.

Integrate transgenes into chromosomes with robust genetic stability, ensuring consistent expression across over 20 passages.
Fast & efficient custom cell engineering, compliant validated cell models for drug R&D.
Inquire Now
Free validation service delivers accurate EC50 and neutralization data, helps you purchase reporter cell lines with greater confidence.
Inquire Now